Disruption of both GLP-1 and GIP signalling pathways in the mouse leads to glucose intolerance

被引:0
|
作者
Preitner, F
Burcelin, R
Ibberson, M
Hansotia, T
Drucker, DJ
Thorens, B
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
268
引用
收藏
页码:A66 / A66
页数:1
相关论文
共 50 条
  • [31] Gene Expression of the GIP and GLP-1 Receptors in the Horse
    Kheder, Murad H.
    Dudley, Kevin
    Sillence, Martin N.
    de Laat, Melody A.
    FASEB JOURNAL, 2017, 31
  • [32] Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
    Janic, Miodrag
    Skrgat, Sabina
    Harlander, Matevz
    Lunder, Mojca
    Janez, Andrej
    Pantea Stoian, Anca
    El-Tanani, Mohamed
    Maggio, Viviana
    Rizzo, Manfredi
    MEDICINA-LITHUANIA, 2024, 60 (12):
  • [33] GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
    Singh, Anmol
    Sohal, Aalam
    Batta, Akash
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (48)
  • [34] Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects
    Vilsboll, T
    Krarup, T
    Madsbad, S
    Holst, JJ
    REGULATORY PEPTIDES, 2003, 114 (2-3) : 115 - 121
  • [35] The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose tolerance
    Marathe, Chinmay S.
    Pham, Hung
    Marathe, Jessica A.
    Trahair, Laurence G.
    Huynh, Lian
    Wu, Tongzhi
    Phillips, Liza K.
    Rayner, Christopher K.
    Nauck, Michael A.
    Horowitz, Michael
    Jones, Karen L.
    ACTA DIABETOLOGICA, 2020, 57 (05) : 583 - 587
  • [36] Response of incretins (GIP and GLP-1) to an oral glucose load in female and male subjects with normal glucose tolerance
    Matsuo, Toshihiro
    Kusunoki, Yoshiki
    Katsuno, Tomoyuki
    Ikawa, Takashi
    Akagami, Takafumi
    Murai, Kazuki
    Miuchi, Masayuki
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (02) : E25 - E29
  • [37] The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose tolerance
    Chinmay S. Marathe
    Hung Pham
    Jessica A. Marathe
    Laurence G. Trahair
    Lian Huynh
    Tongzhi Wu
    Liza K. Phillips
    Christopher K. Rayner
    Michael A. Nauck
    Michael Horowitz
    Karen L. Jones
    Acta Diabetologica, 2020, 57 : 583 - 587
  • [38] Effects of GLP-1 and GIP on Insulin Secretion in Glucose Intolerant, Pancreatic Insufficient Cystic Fibrosis
    Eiel, Jack N.
    Nyirjesy, Sarah
    Peleckis, Amy J.
    De Leon, Diva
    Hadjiliadis, Denis
    Kubrak, Christina
    Tami, Abigail
    Sheikh, Saba
    Rubenstein, Ronald C.
    Kelly, Andrea
    Rickels, Michael R.
    DIABETES, 2018, 67
  • [39] Longitudinal changes in fasting and glucose-stimulated GIP and GLP-1 in healthy older subjects
    Pham, H.
    Phillips, L.
    Marathe, C. S.
    Trahair, L.
    Hatzinikolas, S.
    Huynh, L. Q.
    Wu, T.
    Nauck, M.
    Horowitz, M.
    Rayner, C.
    Jones, K.
    DIABETOLOGIA, 2019, 62 : S128 - S129
  • [40] Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists
    Emanuel, Ezekiel J.
    Dellgren, Johan L.
    Mccoy, Matthew S.
    Persad, Govind
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (20): : 1839 - 1842